NEW YORK (GenomeWeb News) – CompanionDx Reference Lab and Enable Healthcare have partnered to provide physicians in Enable's network access to CompanionDx's pharmacogenomics testing.

Enable's physicians will use CompanionDx's services to make better informed decisions about patient therapies and medications and to identify poor and ultra-rapid metabolizers of drugs, CompanionDx said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.